TWD 59.6
(5.86%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 15.01 Billion TWD | -0.25% |
2022 | 15.05 Billion TWD | 10.2% |
2021 | 13.65 Billion TWD | 34.31% |
2020 | 10.16 Billion TWD | -21.11% |
2019 | 12.89 Billion TWD | 5.53% |
2018 | 12.21 Billion TWD | 4.77% |
2017 | 11.65 Billion TWD | -4.75% |
2016 | 12.24 Billion TWD | -30.0% |
2015 | 17.48 Billion TWD | -0.13% |
2014 | 17.51 Billion TWD | 9.31% |
2013 | 16.01 Billion TWD | -10.15% |
2012 | 17.82 Billion TWD | 5.0% |
2011 | 16.97 Billion TWD | 17.61% |
2010 | 14.43 Billion TWD | -15.86% |
2009 | 17.15 Billion TWD | 0.77% |
2008 | 17.02 Billion TWD | 44.25% |
2007 | 11.8 Billion TWD | 5.36% |
2006 | 11.2 Billion TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 3.29 Billion TWD | 25.27% |
2024 Q2 | 2.91 Billion TWD | -11.48% |
2023 Q4 | 2.63 Billion TWD | -9.81% |
2023 FY | 15.01 Billion TWD | -0.25% |
2023 Q1 | 3.43 Billion TWD | -2.15% |
2023 Q2 | 6.03 Billion TWD | 75.66% |
2023 Q3 | 2.91 Billion TWD | -51.61% |
2022 Q1 | 4.08 Billion TWD | -18.81% |
2022 FY | 15.05 Billion TWD | 10.2% |
2022 Q4 | 3.5 Billion TWD | -5.5% |
2022 Q3 | 3.71 Billion TWD | -0.89% |
2022 Q2 | 3.74 Billion TWD | -8.26% |
2021 Q3 | 3.06 Billion TWD | 17.57% |
2021 Q2 | 2.61 Billion TWD | -11.47% |
2021 FY | 13.65 Billion TWD | 34.31% |
2021 Q1 | 2.94 Billion TWD | 37.1% |
2021 Q4 | 5.02 Billion TWD | 63.86% |
2020 Q3 | 2.56 Billion TWD | 6.03% |
2020 Q4 | 2.15 Billion TWD | -16.26% |
2020 Q1 | 3.02 Billion TWD | -9.6% |
2020 Q2 | 2.42 Billion TWD | -19.99% |
2020 FY | 10.16 Billion TWD | -21.11% |
2019 Q1 | 3.5 Billion TWD | 11.73% |
2019 Q3 | 3.03 Billion TWD | 1.18% |
2019 Q4 | 3.34 Billion TWD | 10.32% |
2019 FY | 12.89 Billion TWD | 5.53% |
2019 Q2 | 3 Billion TWD | -14.39% |
2018 Q2 | 2.93 Billion TWD | -7.44% |
2018 Q4 | 3.13 Billion TWD | 5.78% |
2018 FY | 12.21 Billion TWD | 4.77% |
2018 Q1 | 3.17 Billion TWD | 13.52% |
2018 Q3 | 2.96 Billion TWD | 0.93% |
2017 Q1 | 3.24 Billion TWD | 7.83% |
2017 FY | 11.65 Billion TWD | -4.75% |
2017 Q4 | 2.79 Billion TWD | -0.06% |
2017 Q3 | 2.79 Billion TWD | -0.61% |
2017 Q2 | 2.81 Billion TWD | -13.35% |
2016 Q1 | 3.19 Billion TWD | -38.78% |
2016 FY | 12.24 Billion TWD | -30.0% |
2016 Q2 | 2.84 Billion TWD | -10.84% |
2016 Q3 | 3.18 Billion TWD | 12.06% |
2016 Q4 | 3.01 Billion TWD | -5.53% |
2015 Q1 | 3.83 Billion TWD | -47.31% |
2015 FY | 17.48 Billion TWD | -0.13% |
2015 Q4 | 5.21 Billion TWD | 20.36% |
2015 Q3 | 4.33 Billion TWD | 5.64% |
2015 Q2 | 4.1 Billion TWD | 6.83% |
2014 Q3 | 3.65 Billion TWD | 19.9% |
2014 FY | 17.51 Billion TWD | 9.31% |
2014 Q1 | 3.52 Billion TWD | 7.82% |
2014 Q2 | 3.04 Billion TWD | -13.4% |
2014 Q4 | 7.28 Billion TWD | 99.3% |
2013 Q3 | 3.59 Billion TWD | 10.53% |
2013 Q4 | 3.26 Billion TWD | -9.19% |
2013 Q1 | 5.9 Billion TWD | 9.35% |
2013 Q2 | 3.25 Billion TWD | -44.91% |
2013 FY | 16.01 Billion TWD | -10.15% |
2012 Q4 | 5.4 Billion TWD | 34.53% |
2012 FY | 17.82 Billion TWD | 5.0% |
2012 Q1 | 4.58 Billion TWD | 4.45% |
2012 Q2 | 3.82 Billion TWD | -16.63% |
2012 Q3 | 4.01 Billion TWD | 4.92% |
2011 Q2 | 4.03 Billion TWD | 0.6% |
2011 FY | 16.97 Billion TWD | 17.61% |
2011 Q4 | 4.39 Billion TWD | -3.33% |
2011 Q3 | 4.54 Billion TWD | 12.69% |
2011 Q1 | 4 Billion TWD | 6.04% |
2010 FY | 14.43 Billion TWD | -15.86% |
2010 Q4 | 3.78 Billion TWD | 1.24% |
2010 Q3 | 3.73 Billion TWD | 0.58% |
2010 Q2 | 3.71 Billion TWD | 15.65% |
2010 Q1 | 3.2 Billion TWD | 0.0% |
2009 FY | 17.15 Billion TWD | 0.77% |
2008 FY | 17.02 Billion TWD | 44.25% |
2007 FY | 11.8 Billion TWD | 5.36% |
2006 FY | 11.2 Billion TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Sinon Corporation | 19.11 Billion TWD | 21.441% |
All Cosmos Bio-Tech Holding Corporation | 2.82 Billion TWD | -431.199% |
CH Biotech R&D Co., Ltd. | 1.51 Billion TWD | -891.187% |